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The processes of adsorption of gemcitabine (GC) on the surface of nanosized singledomain magnetite (Fe3O4) 
have been investigated. Under the experiment conditions, the value of adsorption capacity A was ~ 37.2 mg/g, the 
extraction extent U = 33.13 %, the separation factor E = 82.58 mL/g. It has been determined that adsorption 
corresponds to the Freundlich model. The magnetic properties of nanocomposites (NС) Fe3O4@GC have been 
investigated. The average value of the thickness of the adsorbed layer of GC in the composition of Fe3O4@GC NC is 
2.4±0.1 nm, as evaluated by the method of magnetic granulometry. Magnetic liquids (ML) have been synthesized 
based on magnetite and physiological solution (PS) stabilized with sodium oleate (Ol.Na) and polyethylene glycol 
(PEG), which contain GC and antibody (AB) HER2 (Fe3O4@GC/Ol.Na/PEG+PS). The properties of ML were 
investigated as well as cytotoxic/cytostatic activity with respect to HepG2 hepatocellular carcinoma of human liver.  
Parameters of ML based on magnetite were found: Fe3O4 concentration – 14 mg/mL, Fe3O4 particle size –       
4–22 nm, average size of Fe3O4 particles – 10.8 nm; the average size of Fe3O4 particles stabilized with sodium oleate 
– 16.8 nm, saturation magnetization M∞ = 14.1±2.5 % Gs, hypsometric height – 25±10 % cm, viscosity 
η = 1.14±3 % mPa∙s, density ρML = 1.14 ± 1.0 % g/cm3, the concentration of GC was 1.25 mg/mL, that of HER2 AB 
was 3.75 μg/mL. We have obtained the calculated and graphic data concerning the dependence of the surface area 
and the specific magnetization of saturation of Fe3O4@GC/Ol.Na/PEG on the thickness of GC layer, which can be 
useful for predicting of the nanoscale architecture of magnetically sensitive NC and ML in the manufacture of 
relative drugs. The synergistic nature of the influence of GC/Fe3O4/HER2 complex on HepG2 cells was revealed. It 
has been determined that IC50 for ML is 0.155 mg/mL, in the range of concentration of 0.025–0.1 mg/mL, ML is 
biocompatible with HepG2 cells. It has been shown that HER2 AB used alone in the investigated concentrations does 
not affect HepG2 cell viability/proliferation. In vitro, GC inhibits the proliferation of liver carcinoma cells, the IC50 
value has been 0.002 mg/mL. The use of ML in complex with GC can increase the cytotoxic activity of the composite 
by 8–10 %. The ML+GC+HER2 AB complexes caused the synergistic effect and an increase in the cytotoxic activity, 
compared with GC used alone, up to 18–20 %, while GC contents reduced to 0.008 mg/mL. 
The results of the studies indicate that the use of ML based on magnetite, gemcitabine, and antibody increases 
the effectiveness of the antitumor medicines with a significant reduction in their dose and, respectively, the toxico-
allergic reactions of the body, and nanosized magnetite can be promising for the manufacture of magnetically 
sensitive adsorption materials for medical purposes, e.g. for detoxification of an organism after GC therapy. 
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INTRODUCTION 
At the beginning of the 21st century, the 
works in the field of creation of medico-
biological and biotechnological nanomachines 
and “nanoclinics” have got a priority [1–4]. In 
these works [5, 6], the ideas have been 
developed for creation of multilevel 
magnetically sensitive nanocomposites (NC) 
with  a  hierarchical  nanostructure,  which  [7, 8] 
 
have a complex of functions characteristic for 
biomedical nanorobot: recognition of micro-
biological objects in biological environments; 
targeted delivery of medicines to specific cells 
and organs, and deposit; complex therapy with 
chemo-, immune, neutron capture radiation, 
photodynamic, hyperthermic methods and real-
time diagnostics; adsorption of cellular 
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decomposition remnants, ions of heavy metals, 
viral particles, and their removal from the body 
through an external magnetic field. It should be 
noted that for today, the concept of magnetically 
sensitive NC with multilevel hierarchical nanoscale 
architecture and functions of nanorobots was 
experimentally substantiated and confirmed 
through chemical construction of core-shell type 
nanostructures with complex multilevel 
hierarchical structure, their combined research and 
comprehensive check of the capability to perform 
these functions effectively [9–19]. 
For in vitro and in vivo systems, the benefits 
of using of magnetic liquid (ML) compared to 
the traditional use of cisplatin (CP) have been 
proven [20]. It has been found that the biggest 
cytotoxic activity of the nanocomposite, 
indicated in the MCF-7/CP resistance line, is 
related to the most active accumulation of 
ferrimagnetic nanoparticles in cells due to the 
high level of transferrin receptors and the 
disturbance of the antioxidant protection system 
of resistant cells. It has been shown that a 
magnetic liquid is capable to cause more 
pronounced cytomorphological changes and 
genotoxic effects in the cells of the resistance 
line compared to cells of the sensitive line. Thus, 
it has been found that ML on the basis of 
magnetite and cisplatin is characterized by the 
capability to redox regulation of cells with 
phenotype of medicine resistance, which testifies 
the prospect of its use for pathogenetically 
grounded targeted therapy of malignant tumors.  
It has been experimentally shown that the 
use of ML containing NC on the basis of 
magnetite and CP, on the general and 
biochemical parameters of blood does not make 
more toxic effects on the body, compared with 
the official antitumor medicine cisplatin, in 
according doses. 
In papers [16, 21–23] the results are presented 
concerning researches into NC made on the basis 
of nanosized Fe3O4 with modified (by 
hydroxyapatite, aminopropylsiloxane, polyacryl-
amide, etc.) surface, conjugated with CP and 
antibody (AB) CD95. In vitro NC were 
characterized by recognition of MCF-7 human 
breast cancer cells, determined activity of CP, 
CD95, and synergism of their combined activity 
with Fe3O4, which resulted in vitro to the death of 
cells in an amount that exceeded the effect of 
control samples of CP and CD95 in 1.4–2.7 times 
as dependent on the composition of the NC. 
Taking all this into consideration, it is an 
actual task from the scientific and practical point 
of view to clarify the possibility of using of the 
above mentioned approaches to create new 
effective antitumor medicines based on ML, 
containing magnetically sensitive NC, other 
relevant chemotherapeutic medicines and 
antibodies [24–30]. Solving of this task can 
expand the functionality of NCs, improve their 
specificity, promote the creation of new 
multifunctional antitumor medicines for targeted 
delivery and local therapy, and provide new data 
concerning the interaction of oncological drugs 
with tumor cells. 
Therefore, the purpose of this work is to 
synthesize new nanocomposites and magnetic 
liquids based on magnetite, gemcitabine and 
HER2 antibody, to investigate their properties 
and bioactivity in relation to HCC hepatic cells 
of HepG2 line. 
EXPERIMENTAL PART AND DISCUSSION 
In this work, gemcitabine – (2-deoxy-2', 2) 
difluorocytidine monochloride) is used as a drug 
of the chemotherapeutic mechanism of action. It 
is a cytotoxic drug, an antimetabolite from the 
pyrimidine antagonists group. GC belongs to the 
List of the main medicines of the World Health 
Organization and the most effective and safe 
medicines needed in the healthcare system. It is 
characterized by considerable antitumor activity 
for the list of solid tumors (non-small cell lung 
cancer, pancreatic, bladder, breast and ovarian 
cancer), satisfactory endurance and the capability 
to combine successfully with other antitumor 
medicines. It is used for treatment of 
cholangiocarcinoma and other types of biliary 
cancer. The general side effects include bone 
marrow suppression, liver and kidney problems, 
nausea, fever, rash, shortness of breath and hair 
loss [31–34]. Therefore, for today, the possibility 
is actively studied to use GC in composition of 
magnetically sensitive NC and ML on their basis 
to create multi-functional antitumor medicines 
for targeted delivery and local therapy [35–38]. 
In this work as an AB, HER2 (Neu, ErbB-2, 
CD340) was chosen. It is a membrane protein, a 
tyrosine proteinkinase of the EGFR / ErbB 
epidermal growth factor receptor family encoded 
by the human gene ERBB2. Amplification of the 
HER2 gene plays an important role in the 
pathogenesis and progression of certain 
aggressive types of cancer [39–41]. HER2 is an 
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important biomarker and therapeutic target of the 
disease, associated with aggressiveness of the 
tumor and unfavorable prognosis. It is known 
that HER2 AB is considered to be one of the 
optimal for treatment of such diseases as 
gastrointestinal tract cancer, in particular in the 
presence of liver metastasis [42]. Therefore, for 
in vitro researches, we have chosen HER2 AB in 
combination with GC in composition of ML 
based on magnetite.  
Hepatocellular carcinoma (HCC) is the most 
common primary malignant form of liver cancer, 
the result of malignant transformation of 
hepatocytes, a severe, high mortality disease. 
Every year in the world about 600 thousand 
cases of this disease are diagnosed. In order to 
test the antitumor activity of the synthesized ML 
in vitro, the cells of the HCC human liver of 
HepG2 line were selected in this work. 
METHODS OF RESEARCH 
Adsorption of GC on the surface of 
nanosized magnetite was carried out from 
aqueous solutions of different concentration. 
Gemcitabine TEVA (Pharmachemie BV, the 
Netherlands) was used for research. 
Adsorption capacity of samples A (mg/g), 
extraction extent U (%), and separation factor E 
(mL/g) were determined by techniques described 
in [13, 14]. 
The amount of adsorbed substance on the 
surface of magnetite was determined by 
measuring the concentration of GC in contact 
solutions before and after adsorption using a 
spectrophotometer Spectrometer Lambda 
35 UV/Vis Perkin Elmer Instruments. 
Specific surface area (Ssp) of the samples was 
determined by nitrogen thermal desorption by 
means of a KELVIN 1042 device of “COSTECH 
Instruments” firm. The size of NP was 
appreciated by formula DBET = 6/(ρSBET), where 
ρ is density of a particle of NC, SBET is a value of 
specific surface area calculated by the 
polymolecular adsorption theory of Brunauer, 
Emmett and Teller (BЕТ). 
The hysteresis loops of the magnetic 
moment of the samples were measured using a 
laboratory vibration magnetometer of Foner type 
at the room temperature. The description of the 
installation and the method of measurement are 
set out in [43]. To prevent interactions, the 
demagnetized nanoparticles were distributed in 
the paraffin matrix with a volume concentration 
of ~ 0.05. For comparison, materials were used 
with known values of specific saturation 
magnetization (σs): a test sample of nickel and 
Fe3O4 NP (98 %) produced by Nanostructured & 
Amorphous Materials Inc., USA. The 
measurement tolerance of σs did not exceed 
2.5 % with respect to the reference sample. 
To study the effect of experimental samples 
on the viability of hepatocellular carcinoma cells 
of HepG2 line in vitro we used DMEM High 
glucose (Biowest, France, catalog No. L0102-500), 
fetal calf serum (FCS) (Biowest, France, catalog 
No. S181B-500), Versene solution 
(BioTestLaboratoria, Ukraine), a phosphate-salt 
buffer (Sigma, USA, Cat No. D1408), a 
physiological solution (Lekchem, Ukraine, series 
71033007), ethyl alcohol (Ukrspirt, Ukraine), a 
crystalline violet dye (Sigma, USA, Cat No. 
C6158), plastic dishes for cell culture (TPP, 
Italy), 96-well cell culture plates (SPL, Korea). 
The instruments were used: СО2 incubator 
(Heal Force, China), an inverted microscope 
Axiovert 25 (Carl Zeiss, Germany), a Goryaev 
camera (Farmmedtech, Ukraine), a mini-shaker 
PSU-2T (BioSan, Latvia), a multi-band 
spectrophotometer (Labsystems Multiskan 
PLUS, Finland), automatic pipettes up to 20 μl 
(Eppendorf AG, Germany), 200 μl (Thermo 
Fisher Scientific Oy, Finland) and 1000 μl 
(Eppendorf AG, Germany). 
The cells under research were cultured in a 
complete nutrient medium DMEM with 10 % 
FTS and 40 μg/mL of gentamicin in plastic 
dishes in a humidified atmosphere at 5 % СО2 
and 37 °С. The medium changes and transitions 
of the cells were carried out according to the 
standard method [44]. For the experiments we 
used cells that were in the exponential phase of 
growth. After 24–48 h after the last transition, 
the cells were planted for cultivation at a 
concentration of 1–1.5×104 cells /well of 96-well 
cell plate. After 24 h, various amounts of 
experimental substances were added to the 
respective wells according to the study scheme 
and their cytotoxic activity was determined. 
The vitality of cells in the experiment was 
evaluated by means of colorimetric method by 
colouring cells with crystalline violet. Adhesive 
cells are separated from the substrate after death. 
This property is used in order to determine the 
number of living cells after their treatment with 
the investigational agents. One of the ways to 
determine attached (living) cells is to dye them 
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with crystalline violet dye which binds to 
proteins and DNA. The results were evaluated 
using a multi-spectrophotometer (wave length is 
540 nm). The percentage of viable cells was 
calculated according to the formula: 
IR = (A540 (experiment)/A540 (control)) × 100 %. 
The cytotoxic and antiproliferative activity 
was determined using IC50 indicator. 
SYNTHESIS AND PROPERTIES OF 
MAGNETITE 
The synthesis of nanodisperse magnetite was 
carried out according to the method [7], by 
coprecipitation of iron salts according to the 
reaction: 
Fe2++2Fe3++8NH4OHFe3O4+4H2O+8NH4+. 
The synthesized ensembles of Fe3O4 NP 
were characterized by dimensions of 3–23 nm. 
The average size of the NP (d0) depended on the 
synthesis conditions and was 6–13 nm, the size 
distribution could be technologically managed. 
The specific surface area (Ssp) of synthesized 
magnetite, dependent on the average particle 
size, was Ssp = 90–180 m2/g. In this work we 
used specimens for which Ssp = 110±1 % m2/g. 
The value of mean diameter of the NP Fe3O4, 
calculated from the results of studies of X-ray 
diffractograms using the Scherrer formula, DXRD 
was 10.5 nm. Functional OH groups with 
concentration of 2.2 mmol/g were detected in the 
study of infrared spectra of magnetite surface 
[7, 14]. 
The synthesized magnetite is characterized 
by satisfactory magnetic characteristics: the 
coercivity Hc = 55.0±2.5 % Oe, the specific 
magnetization of saturation σs=56.2±2.5 % 
Gs ·cm3/g, relative residual magnetization 
Mr/Ms = 0.2±2.5 %. Such characteristics are 
important for medical and biological applications 
[7, 44], for example, while transporting the 
medicine through blood vessels of small 
diameter, in which the embolization and 
aggregation of particles are extremely 
undesirable. 
In [13, 14] it has been established that the 
synthesized magnetite with the given properties 
is characterized by superparamagnetism of 
nanoparticles and is in a completely single-
domain state. It is known that super-
paramagnetism is a form of magnetism, which is 
manifested in ferro- and ferrimagnetic particles. 
If such particles are of sufficiently small size, 
they are converted into a singledomain state, that 
is, they become homogeneously magnetized 
through the entire volume at any values and 
directions of the field H. To the peculiarities of 
the singledomain state of these particles, one can 
also refer the existence of domains not only in 
alloys and compounds in the solid state, but also 
in liquid media (suspensions and colloids). 
Adsorption of gemcitabine on a surface of 
nanosized Fe3O4. Adsorption of GC on the 
surface of magnetite Fe3O4 was carried out in a 
medium of saline solution in the range of 
concentrations C0 = 0.02–0.67 mg/mL (m = 0.03 g, 
V = 5 mL, pH = 3.0) during 2 h in static mode at 
room temperature. The pH of GC solution 
medium in 0.9 % NaCl was given by 0.1 N HCl. 
From the results of researches into the 
dependence of adsorption activity on pH, the 
maximal values of А (mg/g), U (%) and 
E (mL/g) for Fe3O4 are observed in the acid 
medium at рН = 3. According to the results of 
spectroscopic researches, at the value of рН = 3, 
up to 70 % of GC is in protonated form, which 
corresponds to the medicinal form of 
gemcitabine hydrochloride.  
The isotherm of adsorption of GC on the 
surface of Fe3O4, and the results of its 
mathematical processing are given in Fig. 1. 
For quantitative description of equilibrium 
processes in the investigated range of 
concentrations the Langmuir, Freundlich, and 
BET [45] models were used. Linearized 
equations of these models are used to determine 
the values of the constants (for the Langmuir 
model R2 = 0.849, the Freundlich – 0.996, BЕТ – 
0.948), included in the isotherm equation. 
In our experiments, there has been a 
deviation in the adsorption character from the 
Langmuir scheme, which may be caused by the 
presence of several types of binding centers, 
characterized by different values of equilibrium 
constants (energy heterogeneity) and/or the 
effects of a compatible adsorption. Therefore, we 
have used the Freundlich model (Fig. 1 а, 
Table 1), that describs the isotherm of adsorption 
on a heterogeneous surface: А = КFСр1/n, in the 
linearized form lnA = lnKF + 1/n lnС. 
The experimental values of the adsorption 
capacity А were ~ 37.2 mg/g, the extraction 
extent U = 33.13 %, the separation coefficient 
E = 82.58 mL/g at С0 = 0.67 mg/mL (m = 0.03 g, 
V = 5 mL, pH = 3.0). 
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The results of the studies indicate that 
nanosized magnetite may be promising for the 
producing of magnetically sensitive adsorption 
materials for medical purposes, for example, for 
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Fig. 1. а – Isotherm of adsorption of GC on surface of Fe3O4 (1) and that calculated from the Freundlich equation 
(2); b – the linearized form of the Freundlich isotherm 
 
Table 1. The data of calculations of the adsorption constants of GC on Fe3O4 surface according to Freundlich model 
 
 
Magnetic properties of NC Fe3O4@GC. The 
magnetic properties of Fe3O4@GC 
nanocomposites have been investigated. The 
measured hysteresis loops of magnetite NP, and 
NC with immobilized GC, are shown in Fig. 2  
(σ is specific magnetization, H is magnetic field 
strength). Table 2 shows the magnetic properties 
of magnetite and NC with adsorbed gemcitabine 
derived from experimental hysteresis loops. 
In the table: Hc, Oe – coercive force; σs, emu/g 
– specific magnetization of saturation of NC; σr, 
emu/g – residual specific magnetization of NC; 
σr/σs – relative residual magnetization; αFe3O4calc – 
calculated mass concentration of Fe3O4 in NC, %. 
 















Fig. 2. Hysteresis loops of: 1 – magnetite, 2 – composite Fe3O4@GC. T = 300 K 
Surface С, mg/mL Aexp, mg/g Freundlich model  Аcalc, mg/g КF n R2 Со Ср 
Fe3O4 0.15 0.12 3.87 3.72 18.7 1.28 0.996 
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Table 2. Magnetic characteristics of magnetite and NC with adsorbed GC 
Sample Hc, Oe σs, emu/g σr, emu/g σr/σs αFe3O4calc, % 
Fe3O4 41 57.7 10.4 0.18 100 
Fe3O4@GC 44 39.0 6.07 0.15 68 
 
 















Fig. 3. Histograms of relative frequencies of the diameters of NP Fe3O4 and NC Fe3O4@GC, (d, D, respectively) 
 
The histograms of the relative frequencies of 
the diameters of NP Fe3O4 d and NC Fe3O4@GC 
D (1, 2, respectively) were constructed (Fig. 3) 
using the method of magnetic granulometry and 
assuming that the thickness of GC layers 
depends hardly on the diameter of NP Fe3O4. 
The obtained results are typical for core-
shell type structures. The average value of the 
thickness of the adsorbed layer of GC in the 
composition of NC Fe3O4@GC is 2.4±0.1 nm, as 
evaluated by the method of magnetic 
granulometry. 
Synthesis and properties of magnetic 
liquids. Magnetic liquids (ML) based on 
magnetite and physiological solution (PS) 
stabilized with sodium oleate (Ol.Na) and 
polyethylene glycol (PEG) containing GC 
(Fe3O4@GC/Ol.Na/PEG + PS) were synthesized. 
PS was used as the dispersion medium of 
samples of magnetic liquids for research. It should 
be noted, that the use of distilled water as 
dispersion medium, does not change the magnetic 
properties of colloidal systems substantially. 
Nanosized magnetite was used as a dispersed 
phase, in the singledomain state, or related NC 
Fe3O4@GC. 
To prevent aggregation, Fe3O4 nanoparticles 
and NC were stabilized with sodium oleate 
(C8H17CH=CH(CH2)7CO–O–Na), (dynamic 
mode, 1 h) and polyethylene glycol (PEG-2000). 
The mass of sodium oleate mOl.Na used to 
stabilize the surface of the NP and NC in the 
composition of the ML was calculated taking 
into account the concentration of hydroxyl 
groups on the surface of magnetite. The 
calculation was made using the formula: 
mOl.Na = B∙M∙m, where B is the concentration of 
hydroxyl groups (2.2 mmol/g) on the surface of 
starting nanosized magnetite, M – molecular 
weight of sodium oleate (304 g/mol), m is the 
mass of Fe3O4 or NC. 
It is known that PEG interferes with 
adsorption interactions of liquid components 
with protein molecules [45], which is important 
for medical applications of magnetic liquids. 
Additional modification with PEG-2000 was 
carried out in a dynamic mode using a shaker, 
the amount of polymer was 10–15 % of the 
weight of the bulk of NP Fe3O4, or NC [13, 14]. 
Fig. 4 shows the hysteresis loops of 
aqueous ML Fe3O4@Ol.Na/PEG+PS (1) and 
Fe3O4@GC/Ol.Na/PEG+PS (2). The thickness 
of the layer of GC is ~ 2.3 nm. The thickness of 
the layer of the stabilizer ~ 3 nm, and the 
volumes of water in the ML are the same. 
As known, taking into account the 
distribution of nanocomposite particles by 
volumes p(V), the magnetization curve of ML 
(Fig. 5) can be represented as follows [46]: 
 1
0
( ) ( ) s c sM H p v v M v L x v H dv 

          (1) 
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where φρ is the volume fraction of the magnetic 
component in ML, determined by its density, 
 2 2ln
ln
1( ) exp ln ( / ) / 22 m vv
p v v v
v
       ,  
v – volume of a NC particle, sM – magnetization 
of the saturation of the core, vc – volume of the 
core, 1( )L x cthx x   – Langevin's function, 
s c
B
M v Hx k T
     , χ – magnetic susceptibility of 
the shell, vs – shell volume. The main 
contribution to the magnetization of ML is 
introduced by the superparamagnetism of the 
cores and the paramagnetism of the shells of the 
сore@shell particles. Compared to 
superparamagnetism of cores in the fields           
H = 0–10 kOe, in most cases the paramagnetism 
of the shells (the second term in (1)) can be 
neglected. 
The modification of ML 
Fe3O4@GC/Ol.Na/PEG+PS with AB HER2 
(receiving ML Fe3O4@GC/Ol.Na/PEG/AB 
HER2+PS) was performed dynamically with use 


















Fig. 4. Hysteresis loops of aqueous ML Fe3O4@Ol.Na/PEG+PS (thickness of the stabilizer layer ~ 3 nm) (1) and 
Fe3O4@GC/Ol.Na/PEG+PS (2) 
 
The optimal parameters of the experimental 
ML on the basis of magnetite were evaluated: 
concentration of Fe3O4 – 14 mg/mL, size of 
Fe3O4 particles – 4–22 nm, average size of Fe3O4 
particles – 10.8 nm; the average size of Fe3O4 
particles stabilized with sodium oleate – 16.8 nm; 
saturation magnetization M∞ = 14.1±2.5 % Gs, 
hypsometric height – 25±10 % cm, viscosity 
η = 1.14±3 % mPa·s, density ρМL = 1.14± 
1.0 % g/cm3, the concentration of GC was 
1.25 mg/mL, HER2 AB – 3.75 μg/mL.  
The concentration of GC and AB HER2 in 
such ML is determined by the therapeutic 
necessity. In the starting ML, the concentration 
of GC and AB HER2 has been 1.25 mg/mL and 
3.75 μg/mL, respectively, which allows one 
providing the necessary dosages of the medicine 
in the experimental samples by diluting the 
initial ML. In addition, such a liquid is 
characterized by satisfactory rheological 
properties and sedimentation resistance. 
Investigation of influence of experimental 
samples on viability of HepG2 hepatocellular 
carcinoma cells of human liver in vitro. For the 
research, the series of experimental samples 
were used: 
1. МL: Fe3O4@Ol.Na/PEG+PS (control 1), 
2. Gemcitabine (control 2), 
3. AB HER2 (control 3), 
4. МL + GC:  Fe3O4@GC/Ol.Na/PEG+PS, 
5. ML + АB: Fe3O4@Ol.Na/PEG+PS+HER2, 
6. МL + GC + АB: Fe3O4@GC/Ol.Na/PEG+PS 
+ HER2, 
7. GC + HER2 (control 4), 
8. PS (control 5). 
The concentration of magnetite for all 
systems was CFe3O4 = 3 mg/mL, the 
concentration of gemcitabine CGC = 0.25 mg/mL, 
that of antibody CAB = 0.75 μg/mL. 
According to the results of research into the 
influence of experimental samples on the 
viability of HCC cells of human liver of HepG2 
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line, features were revealed of the influence of 
the composite system ML+GC+AB 
(Fe3O4@GC/Ol.Na/PEG+PS+HER2) and of 
each component separately (ML, GC, AB, PS, 
respectively) on HCC cells.  
In particular: 
1. IC50 for ML was 0.155 mg/mL (control 1). 
In samples with a ML concentration more 
than 0.19 mg/mL, the number of living cells 
is not determined, which is, likely, due to 
high optical density of samples. 
2. The HER2 AB in monoapplication (control 3) 
in the studied concentrations does not affect 
the viability or proliferation of hepatocellular 
carcinoma of human liver cells of the HepG2 
line, as its effect does not decrease the cell 
viability and does not differ practically from 
the influence of PS (control 5). 
3. The cultivation of HepG2 cells at the same 
time in the presence of ML and AB HER2 at 
concentrations less than 0.05 mg/mL and 
0.013 μg/mL, respectively, did not practically 
affect the viability of cells of liver carcinoma. 
However, the complex application of ML and 
HER2 at concentrations of 0.1 mg/mL and 
0.025 μg/mL, respectively, reduced the 
number of viable cells of the said line to        
~ 85.9 %. 
4. IC50 for GC was 0.002 mg/mL (control 2). 
The influence of GC in monoapplication at 
the concentration of 0.008 mg/mL left ~ 78 % 
of cells in a viable state. The use of GC in 
this concentration in combination with ML 
(0.1 mg/mL) showed a synergistic effect and 
increased the effectiveness of cytostatic drug 
up to ~ 10 % (the number of alive cells was 
~ 68 %). 
5. The combined application of GC and AB 
HER2 (control 4) at concentrations of 
0.008 mg/mL and 0.025 μg/mL, respectively, 
also showed a synergistic effect, that resulted 
in a decrease of number of viable cells to       
~ 65 %. 
6. The use of a composite system consisting of 
GC and HER2 at concentrations of 
0.008 mg/mL and 0.025 μg/mL, respectively, 
and ML (0.1 mg/mL with respect to Fe3O4) 
results in a reduction of the number of viable 
cells of HepG2 liver carcinoma to ~ 55 %, 
that indicates a significant synergistic effect 
of the said components. 
The revealed synergistic cytotoxic/cytostatic 
effect can be explained by the high biological 
activity of the complex Fe3O4-GC-HER2 with 
the integrated ligand due to recognition of  
HepG2 tumor cell receptors and pharmacological 
correction of endogenous iron exchange, which 
is ensured by the use of iron-containing ML, GC, 
and HER2 antibodies. 
Indeed, in mechanisms of implementation of 
the apoptosis program due to formation of the 
medicinal effect of NC, violations of the 
exchange of endogenous iron in tumor cells play 
an essential role [47]. The said violations cause 
an increased need of iron for cells, which is 
satisfied by the accumulation of a significant 
number of Fe3O4 nanoparticles with ML. The 
high level of “free iron” in the form of 
accumulated Fe3O4 and acidic medium in the 
cells, causes accelerated formation of iron ions 
and active forms of oxygen (Fenton reaction), 
which in its turn, leads to oxidative stress of cells 
and apoptosis. Thereby an increase occurs also in 
the effectiveness of both GC and HER2 AB. As 
an example we can take the increase up to 
~ 10 % in the action of GC at the concentration 
of 0.008 mg/mL in the composition of ML and 
the appearance of cytotoxic action of the ML+ 
HER2 complex at a level of ~ 10 % at the 
concentration of HER2 of 0.025 μg/mL, 
compared to the absence of activity of AB in 
these doses in monoapplication. 
Thus, the combined effect of ML, GC, and 
HER2 on the HepG2 cells significantly exceeds 
their effects in monouse at the same 
concentrations, which results in synergistic 
effect. 
So, in vitro, an example of the effect of a 
new magnetocarried colloidal system, containing 
magnetite, antitumor component GC and HER2 
antibody, on HCC human liver cells of HepG2 
line shows the possibility to achieve a cytotoxic 
effect at substantially lower concentrations of 
chemo- and immunotherapeutic medicines and to 
create conditions for reducing of toxico-allergic 
reactions of the organism as a whole. In addition, 
the revealed experimental data indicate that the 
investigated MLs can be promising for use in the 
method of targeted delivery and local therapy of 
oncological diseases. 
CONCLUSION 
The processes of adsorption of GC on the 
surface of nanosized singledomain magnetite 
(Fe3O4) have been studied. In the experiment, the 
value of the adsorption capacity A reached 
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~ 37.2 mg/g, the extraction extent U = 33.13 %, 
the separation factor E = 82.58 mL/g. The 
adsorption matching to the Freundlich model has 
been established.  
The NC Fe3O4@GC were synthesized and 
their magnetic properties were investigated. The 
average value of the thickness of the adsorbed 
layer GC (2.4±0.1 nm) in the NC Fe3O4@GC 
was evaluated through the method of magnetic 
granulometry. 
The ML were synthesized based on 
magnetite and PS, stabilized with Ol.Na and 
PEG, containing GC and HER2 AB 
(Fe3O4@GC/Ol.Na/PEG + PS). The properties of 
ML were studied as well as cytotoxic/cytostatic 
activity in relation to HCC of human liver of 
HepG2 line. 
The obtained data can be useful for 
predicting of the nanoscale architecture of 
magnetically sensitive NC and ML in the 
production of medicines on their basis. 
The synergistic nature of the effect of 
GC/Fe3O4/HER2 complex on HepG2 cells was 
revealed. It has been shown that HER2 AB alone 
does not affect HepG2 cell viability/ 
proliferation in investigated concentrations. 
GC suppressed cell proliferation of liver 
carcinoma, the IC50 value was 0.002 mg/mL in 
vitro. The use of ML in combination with GC 
can increase the cytotoxic activity of the 
composite up to 8–10 %. The ML + GC + HER2 
complexes caused a synergistic effect and 
increased the cytotoxic activity, compared with 
GC in monouse, to 18–20 %, while GC content 
reduced to 0.008 mg/mL. 
The results of the studies indicate that the 
use of ML on the basis of magnetite, 
gemcitabine and antibody increases the 
effectiveness of the antitumor medicines with a 
significant reduction in their dose and, 
respectively, the toxico-allergic reactions of the 
body, and nanosized magnetite may be 
promising for the manufacture of magnetically 
sensitive adsorption materials for medical 
purposes, for example, detoxification of an 
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Досліджено процеси адсорбції гемцитабіну (ГЦ) на поверхні нанорозмірного однодоменного магнетиту 
(Fe3O4). В умовах експерименту значення адсорбційної ємності А становило ~ 37.2 мг/г, ступінь вилучення  
U = 33.13 %, коефіцієнт розділення E = 82.58 мл/г. Встановлено відповідність  адсорбції моделі Фрейндліха. 
Досліджено магнітні властивості нанокомпозитів (НК) Fe3O4@ГЦ. Методом магнітної гранулометрії 
оцінено середнє значення товщини адсорбованого шару ГЦ у складі НК Fe3O4@ГЦ, яке становить 
2.4±0.1 нм. Синтезовано магнітні рідини (МР) на основі магнетиту і фізіологічного розчину (ФР), 
стабілізовані олеатом натрію (Ol.Na) і поліетиленгліколем (PEG), що містять ГЦ та антитіло (АТ) HER2 
(Fe3O4@ГЦ/Ol.Na/PEG+ФР). Досліджено властивості МР та цитотоксичну/цитостатичну активність 
щодо гепатоцелюлярної карциноми (ГЦК) печінки людини лінії HepG2. Встановлено параметри МР на основі 
магнетиту: концентрація Fe3O4 – 14 мг/мл, розмір частинок Fe3O4 – 4–22 нм, середній розмір частинок 
Fe3O4 – 10.8 нм; середній розмір частинок Fe3O4, стабілізованих олеатом натрію – 16.8 нм; намагніченість 
насичення М∞ = 14.1±2.5 % Гс, гіпсометрична висота – 25±10 % см, в’язкість η = 1.14±3 % мПа∙с, густина 
ρМР = 1.14 ±1.0 % г/см3, концентрація ГЦ становила 1.25 мг/мл, АТ HER2 – 3.75 мкг/мл. Отримані 
розрахункові та графічні дані  щодо залежності питомої площі поверхні і питомої намагніченості 
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насичення НК Fe3O4@ГЦ/Ol.Na/PEG від товщини шару ГЦ можуть бути корисними для прогнозування 
наноархітектури магніточутливих НК і МР при виготовленні лікарських засобів на їхній основі. Виявлено 
синергічний характер ефекту впливу комплексу ГЦ/Fe3O4/HER2 на клітини HepG2. Встановлено, що ІС50 
для МР становить 0.155 мг/мл, у діапазоні концентрацій 0.025–0.1 мг/мл МР є біосумісною з клітинами 
HepG2. Показано, що АТ HER2 у монозастосуванні в досліджених концентраціях не впливає на 
життєздатність/проліферацію клітин HepG2. ГЦ пригнічує проліферацію клітин карциноми печінки, 
значення ІС50 становило 0.002 мг/мл in vitro. Використання МР в комплексі з ГЦ дозволяє підвищити 
цитотоксичну активність композиту на 8–10 %. Комплекси МР+ГЦ+АТ HER2 спричиняли синергічний 
ефект та підвищення цитотоксичної активності, порівняно з ГЦ у монозастосуванні, до 18–20 %, при 
цьому вміст ГЦ зменшувався до 0.008 мг/мл. 
Результати досліджень свідчать, що використання МР на основі магнетиту, гемцитабіну та 
антитіла підвищує ефективність дії протипухлинних препаратів при істотному зменшенні їх дози та, 
відповідно, токсико-алергічних реакцій організму, а нанорозмірний магнетит може бути перспективним для 
виготовлення магніточутливих адсорбційних матеріалів медичного призначення, наприклад, для 
детоксикації організму після терапії ГЦ. 
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Исследованы процессы адсорбции гемцитабина (ГЦ) на поверхности наноразмерного однодоменного 
магнетита (Fe3O4). В условиях эксперимента значение адсорбционной емкости А составило ~ 37.2 мг/г, 
степень извлечения U = 33.13 %, коэффициент разделения E = 82.58 мл/г. Установлено соответствие 
адсорбции модели Фрейндлиха. Исследованы магнитные свойства нанокомпозитов (НК) Fe3O4@ГЦ. 
Методом магнитной гранулометрии оценено среднее значение толщины адсорбированного слоя ГЦ в 
составе НК Fe3O4 @ ГЦ, которое составляет 2.4±0.1 нм. Синтезированы магнитные жидкости (МЖ) на 
основе магнетита и физиологического раствора (ФР), стабилизированные олеатом натрия (Ol.Na) и 
полиэтиленгликолем (PEG), содержащие ГЦ и антитело (АТ) HER2 (Fe3O4@ГЦ/Ol.Na/PEG+ФР). 
Исследованы свойства МЖ и цитотоксическое/цитостатическое действие в отношении 
гепатоцеллюлярной карциномы (ГЦК) печени человека линии HepG2. Установлены параметры МЖ на 
основе магнетита: концентрация Fe3O4 – 14 мг/мл, размер частиц Fe3O4 – 4–22 нм, средний размер частиц 
Fe3O4 – 10.8 нм; средний размер частиц Fe3O4, стабилизированных олеатом натрия – 16.8 нм; 
намагниченность насыщения М∞ = 14.1±2.5 % Гс, гипсометрическая высота – 25±10 % см, вязкость 
η = 1.14±3 % мПа∙с, плотность ρМЖ = 1.14±1.0 % г/см3, концентрация ГЦ составила 1.25 мг/мл, АТ HER2 – 
3.75 мкг/мл. Полученные расчетные и графические данные о зависимости удельной площади поверхности и 
удельной намагниченности насыщения НК Fe3O4@ГЦ/Ol.Na/PEG от толщины слоя ГЦ могут быть 
полезными для прогнозирования наноархитектуры магниточувствительных НК и МЖ при изготовлении 
лекарственных средств на их основе. Выявлено синергический характер эффекта воздействия комплекса 
ГЦ/Fe3O4/HER2 на клетки HepG2. Установлено, что IC50 для МЖ составляет 0.155 мг/мл, в диапазоне 
концентраций 0.025–0.1 мг/мл МЖ характеризуется биосовместимостью с клетками HepG2. Показано, 
что АТ HER2 при моноиспользовании в исследованных концентрациях не влияет на жизнеспособность / 
пролиферацию клеток HepG2. ГЦ подавляет пролиферацию клеток карциномы печени, значение IC50 
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составляло 0.002 мг/мл in vitro. Использование МЖ в комплексе с ГЦ позволяет повысить цитотоксическую 
активность композита на 8–10 %. Комплексы МЖ + ГЦ + АТ HER2 вызывали синергический эффект и 
повышение цитотоксической активности, по сравнению с ГЦ в моноприменении, до 18–20 %, при этом 
содержание ГЦ уменьшалось до 0.008 мг/мл. 
Результаты исследований свидетельствуют, что использование МЖ на основе магнетита, 
гемцитабина и антитела повышает эффективность действия противоопухолевых препаратов при 
существенном уменьшении их дозы и, соответственно, токсико-аллергических реакций организма, а 
наноразмерный магнетит может быть перспективным для изготовления магниточувствительных 
адсорбционных материалов медицинского назначения, например, для детоксикации организма после 
терапии ГЦ. 
Ключевые слова: магнетит, магнитная жидкость, гемцитабин, антитело HER2, гепатоцеллюлярная 
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